Progenitor Cells Role in Restenosis and Atherosclerosis
NCT01575431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2020-04-09
Summary
The aim of this study is to prospectively investigate the relationship of circulating endothelial progenitor cells at time of percutaneous coronary intervention to the subsequent development of in-stent restenosis or progression of coronary atherosclerosis.
Conditions
Sponsors & Collaborators
-
University of Roma La Sapienza
lead OTHER
Principal Investigators
-
Francesco Pelliccia, MD · University La Sapienza
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2014-12-31
- Completion
- 2020-04-30
Countries
- Italy
Study Locations
More Related Trials
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
NCT00349895 ·Status: COMPLETED ·Phase: PHASE4
-
Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA)
NCT01255956 ·Status: UNKNOWN ·Phase: PHASE3
-
Self-apposing Stentys Stents Registry
NCT02784405 ·Status: UNKNOWN
-
The 3D Stent Study
NCT06898021 ·Status: RECRUITING
-
Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions
NCT02360709 ·Status: UNKNOWN
-
The ILLUMINA Study. (ILLUMINA)
NCT03510676 ·Status: COMPLETED ·Phase: NA
-
Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries
NCT00732953 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
NCT01556126 ·Status: COMPLETED ·Phase: NA
-
Focal In-stent Restenosis After Drug-Eluting Stent
NCT00485004 ·Status: COMPLETED ·Phase: PHASE4
-
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
NCT00279006 ·Status: UNKNOWN ·Phase: NA
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
NCT00811772 ·Status: COMPLETED ·Phase: NA
-
Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis
NCT03167424 ·Status: UNKNOWN
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
NCT03452293 ·Status: COMPLETED
-
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
NCT00611910 ·Status: COMPLETED ·Phase: PHASE4
-
The Cre8™ BTK Post Market Clinical Follow-up Study
NCT05616156 ·Status: UNKNOWN
-
Retrospective Study of the Impact of Drug Eluting Stents
NCT00487604 ·Status: UNKNOWN
-
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
NCT02313038 ·Status: COMPLETED
-
Antiplatelet Therapy Following Stent Implantation
NCT02051361 ·Status: COMPLETED
-
A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis
NCT03373695 ·Status: COMPLETED ·Phase: NA
-
Genetics Study of In-stent Restenosis
NCT01670396 ·Status: UNKNOWN
-
Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease
NCT02800837 ·Status: UNKNOWN